The CBI could not question the accused arrested by it even after seven days, officials said and expressed apprehension that the delay might impede the investigation.
New Delhi: In line with the Risk Assessment Form released by Cordis Cashel, Ireland, the Central Drugs Standard Control Organization (CDSCO) has issued a Medical Device Alert for PALMAZ GENESIS.
The Indian Pharmacopoeia Commission has published the Indian Pharmacopoeia 2022 to supplement the current Indian Pharmacopoeia – the book of standards under the Drugs and Cosmetics Act,1940. IP 2022 is likely to be effective from December 1, 2022.
Recent corruption charges against the CDSCO, Synergy Network India and Biocon Biologics have put to the fore to look minutely into the core of the issues and eradicate tainted officials from the system
CBI has claimed Joint Drugs Controller S. Eswara Reddy allegedly received a Rs 4 lakh bribe to waive phase-three clinical trials of the Insulin Aspart injection, a product under development at Biocon Biologics.